Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (PLX) has reported earnings 21 times since May 14, 2021. The stock moves an average of ±9.09% the day after reporting, closing higher 47.6% of the time. Its largest post-earnings gain was +14.46% (Aug 07, 2023) and its largest decline was -40.48% (May 09, 2025). The next earnings report is predicted for 2026-08-14 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±9.09%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | ☀ PRE | $1.98 | $2.17 | $1.95 | 144,741 | +2.37% | open_in_new |
| Mar 18, 2026 | ☀ PRE | $2.28 | $2.32 | $2.21 | 3,359,000 | -20.79% | open_in_new |
| Nov 13, 2025 | ☀ PRE | $1.84 | $2.04 | $1.93 | 1,523,500 | -9.81% | open_in_new |
| Aug 14, 2025 | ☀ PRE | $1.56 | $1.60 | $1.52 | 933,700 | -5.59% | open_in_new |
| May 09, 2025 | ☀ PRE | $2.39 | $2.39 | $1.72 | 5,949,700 | -40.48% | open_in_new |
| Mar 17, 2025 | ☀ PRE | $2.37 | $2.65 | $2.45 | 1,968,100 | +9.37% | open_in_new |
| Nov 14, 2024 | ☀ PRE | $1.26 | $1.41 | $1.41 | 1,466,100 | +13.71% | open_in_new |
| Aug 14, 2024 | ☀ PRE | $1.04 | $1.04 | $0.93 | 624,900 | -10.58% | open_in_new |
| May 10, 2024 | ☀ PRE | $1.04 | $1.14 | $1.10 | 2,178,100 | -12% | open_in_new |
| Mar 14, 2024 | ☀ PRE | $1.54 | $1.54 | $1.37 | 1,249,500 | -9.87% | open_in_new |
| Nov 06, 2023 | ☀ PRE | $1.68 | $1.70 | $1.51 | 1,691,400 | -18.38% | open_in_new |
| Aug 07, 2023 | ☀ PRE | $1.90 | $1.93 | $1.90 | 5,270,200 | +14.46% | open_in_new |
| May 18, 2023 | ☀ PRE | $2.24 | $2.29 | $2.14 | 4,434,700 | -9.32% | open_in_new |
| Feb 27, 2023 | ☀ PRE | $1.80 | $2.02 | $1.87 | 2,418,900 | +2.75% | open_in_new |
| Nov 14, 2022 | ☀ PRE | $1.08 | $1.11 | $1.07 | 211,900 | +1.9% | open_in_new |
| Aug 15, 2022 | ☀ PRE | $1.21 | $1.24 | $1.24 | 116,100 | +0.81% | open_in_new |
| May 16, 2022 | ☀ PRE | $1.05 | $1.14 | $1.07 | 155,600 | +0.94% | open_in_new |
| Mar 31, 2022 | ☀ PRE | $1.05 | $1.14 | $1.06 | 1,099,300 | +0.95% | open_in_new |
| Nov 15, 2021 | ☀ PRE | $1.10 | $1.29 | $1.15 | 6,425,300 | +0.88% | open_in_new |
| Aug 16, 2021 | ☀ PRE | $1.37 | $1.37 | $1.32 | 719,600 | -1.49% | open_in_new |
| May 14, 2021 | ☀ PRE | $2.93 | $2.93 | $2.74 | 1,524,100 | -4.53% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±9.09%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260521 | open_in_new SEC.gov |
| 10-Q | 20260513 | open_in_new SEC.gov |
| 8-K | 20260513 | open_in_new SEC.gov |
| ARS | 20260430 | open_in_new SEC.gov |
| DEF 14A | 20260430 | open_in_new SEC.gov |
| 3/A | 20260427 | open_in_new SEC.gov |
| 3/A | 20260427 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260330 | open_in_new SEC.gov |
| 10-K | 20260318 | open_in_new SEC.gov |
| 8-K | 20260318 | open_in_new SEC.gov |
Frequently asked about PLX earnings
When does Protalix BioTherapeutics, Inc. report earnings next? expand_more
Protalix BioTherapeutics, Inc. (PLX)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does PLX stock move after earnings? expand_more
Over 21 reports, PLX has moved an average of ±9.09% the session after earnings, closing higher 47.6% of the time.
What was PLX's biggest post-earnings move? expand_more
PLX's largest post-earnings gain on record was +14.46% on Aug 07, 2023, and its largest decline was -40.48% on May 09, 2025.
Where can I find Protalix BioTherapeutics, Inc.'s SEC filings? expand_more
All of Protalix BioTherapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right